ArticleBiotechnology and bioengineering2022

Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools.

Rita Agostinetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.